Correlation Between Spruce Biosciences and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Spruce Biosciences and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spruce Biosciences and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spruce Biosciences and Candel Therapeutics, you can compare the effects of market volatilities on Spruce Biosciences and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spruce Biosciences with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spruce Biosciences and Candel Therapeutics.
Diversification Opportunities for Spruce Biosciences and Candel Therapeutics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Spruce and Candel is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Spruce Biosciences and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Spruce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spruce Biosciences are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Spruce Biosciences i.e., Spruce Biosciences and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Spruce Biosciences and Candel Therapeutics
Given the investment horizon of 90 days Spruce Biosciences is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Spruce Biosciences is 2.87 times less risky than Candel Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 465.00 in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of 310.00 from holding Candel Therapeutics or generate 66.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spruce Biosciences vs. Candel Therapeutics
Performance |
| Timeline |
| Spruce Biosciences |
| Candel Therapeutics |
Spruce Biosciences and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spruce Biosciences and Candel Therapeutics
The main advantage of trading using opposite Spruce Biosciences and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spruce Biosciences position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Spruce Biosciences vs. Inozyme Pharma | Spruce Biosciences vs. Day One Biopharmaceuticals | Spruce Biosciences vs. Terns Pharmaceuticals | Spruce Biosciences vs. Eledon Pharmaceuticals |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |